Literature DB >> 15780822

Cardiovascular complications in diabetes mellitus.

Burton E Sobel1, David J Schneider.   

Abstract

Diabetes is strongly associated with coronary, cerebral and peripheral arterial disease, as well as with microangiopathy. In those with diabetes, the extent of macrovascular disease increases and atherosclerotic plaques are more prone to rupture. Both hormonal abnormalities (insulin resistance that is typically present for many years before the onset of type 2 diabetes) and metabolic abnormalities contribute. Multi-targeted intensive therapy is imperative; however, unfortunately it is underutilized. Functional and structural derangements contribute to impaired arterial and ventricular compliance predisposing to congestive heart failure that is increasingly recognized to be a cause of morbidity and mortality in patients with diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 15780822     DOI: 10.1016/j.coph.2005.01.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  17 in total

1.  A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.

Authors:  Dominic P Tilden; Segundo Mariz; Gillies O'Bryan-Tear; Julia Bottomley; Alexander Diamantopoulos
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  Vitamin C supplementation reconstitutes polyfunctional T cells in streptozotocin-induced diabetic rats.

Authors:  Gamal Badr; Samir Bashandy; Hossam Ebaid; Mohamed Mohany; Douaa Sayed
Journal:  Eur J Nutr       Date:  2011-02-25       Impact factor: 5.614

Review 3.  Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).

Authors:  Badar Ul Islam; Safia Habib; Parvez Ahmad; Shaziya Allarakha; Asif Ali
Journal:  Indian J Clin Biochem       Date:  2015-01-20

4.  Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada.

Authors:  Daria J O'Reilly; Feng Xie; Eleanor Pullenayegum; Hertzel C Gerstein; Janet Greb; Gord K Blackhouse; Jean-Eric Tarride; Jim Bowen; Ron A Goeree
Journal:  Qual Life Res       Date:  2011-01-08       Impact factor: 4.147

Review 5.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Curr Opin Pharmacol       Date:  2006-02-17       Impact factor: 5.547

7.  Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats.

Authors:  I-Min Liu; Cheng Kuei Chang; Shiow-Wen Juang; Dai-Huang Kou; Yat-Ching Tong; Kai-Chun Cheng; Juei-Tang Cheng
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

8.  Beta-adrenergic receptor mediated protection against doxorubicin-induced apoptosis in cardiomyocytes: the impact of high ambient glucose.

Authors:  Naohiro Yano; Daisuke Suzuki; Masayuki Endoh; Andy Tseng; Joan P Stabila; Bethany G McGonnigal; Ting C Zhao; James F Padbury; Yi-Tang Tseng
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

9.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

10.  Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases.

Authors:  Luca Degli Esposti; Stefania Saragoni; Stefano Buda; Alessandra Sturani; Ezio Degli Esposti
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.